References
- Seminars in Cancer Biol. v.9 Human papillomavirus vaccines. Breitburd,F.;P.Coursaget.
- Virology v.293 Yeast coexpression of human papillomavirus types 6 and 16 capsid protein. Buonamassa,D.T.;C.E.Greer;S.Capo;T.S.B.Yen;C.L.Galeotti;G.BENSI.
- Virology v.182 Expression fo human papillomavirus proteins in yeast Saccharomyees Cerevisiae. Carter,J.J.;N.Yaegashi;S.A.Jenison;D.A.Galloway.
- Cancer Lett. v.162 Improvement of gene transfer to cervical cancer cell lines using non-viral agents. Cho,C.W.;Y.S.Cho;B.T.Kang;J.S.Hwang;S.N.Park;D.Y.Yoon
- J. Infect. Dis. v.183 no.10 A Phase 1 study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers. Evans,T.G.;W.Bonnez;R.C.Rose;S.Koenig;L.Demeter;J.A.Suzich;D.O’Brien;M.Campbell;W.I.White;J.Balsley;R.C.Reichman
- J. Virol. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile Enterotoxin Mutant R192G or CpG DNA. Gerber,S.;C.Lane;D.M.Brown;E.Lord;M.Dilorenzo;J.D.Clements;E.Rybicki;A.L.Williamson;R.C.Rose.
- J.Virol. v.67 Self-assembiy of human papillomavirus type 1 capsids by expression of the L1 protein alone or by oexpression of the L1 and L2 capsid proteins. Hagensee,M.E.;N.Yaegashi;D.A.Galloway.
- J. Natl.Cancer Inst. v.93 no.4 Papillomavirus 16L1 virus-like paticle vaccine Harro,C.D.;Y.S.Pang;R.B.S.Rose;A.Hildesheim;Z.Wang;M.J.Reynolds;T.C.Mast;R.Robinson;B.R.Murphy;R.A.Karron;J.Dillner;T.Schiller;D.R.Lowy.
- Vaccine v.13 Vaccination with yeast-expressed cottontail rabbits papillomavirus(CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Jansen,K.U.;M.Rosolowsky;L.D.Schultz;H.Z.Markus;J.C.Cook;J.J.Donnelly;D.Martinez;R.W.Ellis;A.R.Shaw.
- Biomed. Pharmacother. v.53 Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein. Le Buanec,H.;A.Lachger;R.D’Anna;J.F.Zagury;B.Bizzini;J.Bernard;D.Ittele;S.Hallez;C.Giannouli;A.Burny;D.Zaguty.
- J. Immunol.2001 v.166 Papillomavirus-like particles induce acute activation of dendritic cells. Lenz,P.;P.M.Day;Y.S.Pang;S.A.Frye;P.N.Jensen;D.R.Lowy;J.T.Schiller.
- Proc. Nalt. Acad.Sci.USA. v.91 Genital human papillomavirus infection. Lowy,D.R.;R.Kirnbauer;J.T.Schiller.
- J. Virol.1996 Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. Roden,R.A.S;N.L.Hubbert;R.Kirnbauer;N.D.Chridtensen;D.R.Lowy;J.T.Schiller.
- Virology v.270 Minor Capsid protein of human genital papillomaviruses contains subdominant, cross-neutalizing epitoper. Roden,R.B.S.;W.H.Yutzy;R.Fallon;S.Inglis;D.R.Lowy;J.T.Schiller.
- Hum. Gene Ther. v.11 Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Rossi,J.L.;L.Gissmann;K.Jansen;M.Muller.
- J. Clinic. Virol. v.19 Deneloping HPV virus-like particle vaccines to prevent cervical cancer: a prohress report. Schiller,J.T.;A.Hidesheim.
- Seminars in Cancer Biol. v.7 Papillomavirus0like particles and HPV vaccine development. Schiller,J.T.;D.R.Lowy.
- J. Microbiol. v.40 Histological alteration and immune response inducde by pet toxin during colonization with enteroaggregative Escherichia coli(EAEC) in a mouse midel infection. Teresita, S.;J.Perez;M.C.Fresan;V.Flotes;L.Jimenez;U.Hernandez;I.Herrera;C.Eslava.
- Biochem. Biophys. Res.Commun. v.283 no.3 Alpha(6) Integrin id the main receptor of human papillomavirus type 16VLP. Yoon,C.S.;K.D.Kim,;S.N.Park;S.W.Cheong.
- Virology v.189 Definition of liner antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Zhou,J.;X.Y.Sun;H.Davies;L.Crawford;D.Park;I.H.Fraxer.